Adar Poonawalla

Why Serum Institute’s qHPV vaccine, India’s first against cervical cancer, is a game-changer

Cervavac, India’s first vaccine to fight cervical cancer, will be launched today. This vaccine will be both affordable and accessible for millions of women vulnerable to the disease

Monkeypox won't be pandemic as big as COVID, we're working on vaccine: Adar Poonawalla

The SII CEO was honoured with the 'Amrit Ratna Samman' at the News18 India event in Delhi on Tuesday

SII might have to destroy 200 million COVID-19 vaccines due to oversupply, says Adar Poonawalla

The Serum Institute of India’s chief executive is advocating a global pandemic treaty and proposing that next time there is a framework for leaders to work with rather than having to negotiate

Invest in making Tesla cars in India, Adar Poonawalla to Elon Musk

Elon Musk, the world's richest individual, recently struck a deal to buy Twitter for $44 billion

SII's COVID-19 vaccine Covovax now available for children in India: Adar Poonawalla

SII's CEO Adar Poonawalla said the vaccine is in line with Prime Minister Narendra Modi's 'vision of providing yet another vaccine to protect our children'

Adar Poonawalla warns against return to business-as-usual approach

He pointed out that there is rising vaccine fatigue among the public as the main reason for the low off-take of the vaccines even after the firm has massively slashed the price from Rs 600 to Rs 225 a dose

COVID-19: Indian vaccines better than Pfizer, Moderna, says Adar Poonawalla

The COVID-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and Moderna, said Adar Poonawalla

COVID-19: Indian vaccines sold in Europe for first time, says Adar Poonawalla; lauds Centre's work during pandemic

On 9 April, Poonawalla said in a tweet that SII had decided to revise the price of Covishield vaccine for private hospitals from Rs 600 to Rs 225 per dose

Serum Institute seeks emergency use authorisation for its rBCG tuberculosis vaccine

India's TB immunisation programme currently offers BCG vaccination at birth or as early as possible till one year of age

Why India's vaccine advisory body recommends reducing second-dose gap for Covishield

The National Technical Advisory Group on Immunisation has recommended that the gap between the first and second dose of Covishield should be reduced to eight to 16 weeks, from the current gap of 12 to 16